---
title: Effects of Navigation Versus Conventional Total Knee Arthroplasty on the Levels of Inflammation Markers
nct_id: NCT03163888
overall_status: COMPLETED
sponsor: Chang Gung Memorial Hospital
study_type: OBSERVATIONAL
primary_condition: Arthroplasty Complications
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03163888.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03163888"
ct_last_update_post_date: 2017-05-23
last_seen_at: "2026-05-12T06:15:12.385Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Effects of Navigation Versus Conventional Total Knee Arthroplasty on the Levels of Inflammation Markers

**Official Title:** Effects of Computer Navigation Versus Conventional Total Knee Arthroplasty on the Levels of Inflammation Markers: A Prospective Comparative Study

**NCT ID:** [NCT03163888](https://clinicaltrials.gov/study/NCT03163888)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 200
- **Lead Sponsor:** Chang Gung Memorial Hospital
- **Conditions:** Arthroplasty Complications, Inflammatory Response
- **Start Date:** 2000-01-01
- **Completion Date:** 2017-05-01
- **CT.gov Last Update:** 2017-05-23

## Brief Summary

Total knee arthroplasty (TKA) is a well-established modality for the treatment of advanced knee osteoarthritis with high satisfaction rate. However, the traditional cutting jigs for distal femur cutting inevitably violates the medullary canal of femoral bone. The process of intramedullary reaming for the insertion of distal femur cutting jigs stimulated the dissipation of marrow emboli that reported lead to increased risk of myocardial infarction or cardiac stress perioperatively. There are emerging refinements aiming to reduce the insult to the medullary canal of the distal femur as well as to improve the prosthetic alignment, such as navigation assisted TKA or robotic surgery.

In addition to better prosthetic alignment, computer-assisted navigation TKAs also mitigate perioperative blood loss and systemic emboli. The publication previously published by the investigators showed that navigation TKAs can lead to lesser extent of elevation of endothelial injury markers than the traditional TKAs. However, the detrimental effects of intramedullary reaming seem to be multi-dimensional and the whole picture has not been elucidated clearly at present.

Previous studies have shown that operative trauma can trigger marked immune responses. Operative procedures can simultaneously stimulate the pro-inflammatory and anti-inflammatory response, with 80% of the leucocyte transcriptome being affected. Most studies of hip or knee surgery found that operation-triggered immune reactions are associated with postoperative recovery, infection, and even mortality.

The navigation TKAs avoid the process of intra-medullary reaming, which is the mandatory part of conventional TKA for the distal femur cutting. The investigators hypothesize that the reaming process may exert substantial inflammatory response, which can be manifested by higher level of inflammatory markers in the serum and hemovac drainage samples obtained from the participants undergoing conventional TKAs.

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* end stage knee OA necessitating TKR surgeries

Exclusion Criteria:

* autoimmune diseases, malignancies, previous knee surgery or post-traumatic arthritis
```

## Arms

- **Navigation TKR group** — TKR performed under computer navigation without violating distal femur bone marrow.
- **Conventional TKR group** — TKR performed under conventional distal femur cutting juts with violation of distal femur bone marrow.

## Interventions

- **Navigation TKR** (PROCEDURE) — Traditional over Conventional TKR

## Primary Outcomes

- **Concentration of IL-6(pg/mL)** _(time frame: 24 hours after TKR)_ — serum level change from baseline 24 hours after TKR , hemovac level 24 hours after TKR

## Secondary Outcomes

- **Concentration of IL-10(pg/mL)** _(time frame: 24 hours after TKR)_
- **Concentration of TNF-alpha (pg/mL)** _(time frame: 24 hours after TKR)_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03163888.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03163888*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*